Bengaluru, India

M Naveen Sadhu

This inventor holds 1 USPTO granted patent. Top assignee: Blueprint Medicines Corporation. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: M Naveen Sadhu. Retrieved from https://idiyas.com/inventor/m-naveen-sadhu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: M Naveen Sadhu: Innovator in Pyrimidine Compounds

Introduction

M Naveen Sadhu is a prominent inventor based in Bengaluru, India. He has made significant contributions to the field of medicinal chemistry, particularly through his work on pyrimidine compounds. His innovative approach has led to advancements in pharmaceutical applications, showcasing his expertise and dedication to research.

Latest Patents

M Naveen Sadhu holds 1 patent related to pyrimidine compounds, titled "Pyrimidine compounds, compositions, and medicinal applications thereof." This patent encompasses a class of pyrimidine compounds, their stereoisomers, tautomers, and pharmaceutically acceptable salts. The disclosure also details a process for preparing these compounds, along with their medicinal applications and pharmaceutical compositions.

Career Highlights

He is currently associated with Blueprint Medicines Corporation, where he continues to push the boundaries of medicinal research. His work has been instrumental in developing new therapeutic options, reflecting his commitment to improving healthcare outcomes.

Collaborations

M Naveen Sadhu collaborates with talented professionals in his field, including Michael Rajesh Stephen and Naveena Madhyastha. These partnerships enhance the innovative potential of their research endeavors.

Conclusion

M Naveen Sadhu's contributions to the field of medicinal chemistry, particularly through his work on pyrimidine compounds, highlight his role as a key innovator. His ongoing research and collaborations promise to yield further advancements in pharmaceutical applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…